339 related articles for article (PubMed ID: 15122789)
1. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
3. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy].
Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J
Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
Richardus JH; Vos D; Veldhuijzen IK; Groen J
J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
[TBL] [Abstract][Full Text] [Related]
5. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
6. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study.
Domínguez A; Bruguera M; Plans P; Espuñes J; Costa J; Plasencia A; Salleras L
BMC Infect Dis; 2007 Jul; 7():73. PubMed ID: 17610736
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
Wong KH; Liu YM; Ng PS; Young BW; Lee SS
J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
[TBL] [Abstract][Full Text] [Related]
9. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
10. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis a in Lebanon: a changing epidemiological pattern.
Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
[TBL] [Abstract][Full Text] [Related]
12. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
[TBL] [Abstract][Full Text] [Related]
13. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.
Costas L; Vilella A; Trilla A; Serrano B; Vera I; Roldán M; Sancho MP; Bayas JM; Gascón J; Costa J
J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
15. Decline of maternal hepatitis a antibodies during the first 2 years of life in infants born in Turkey.
Derya A; Necmi A; Emre A; Akgün Y
Am J Trop Med Hyg; 2005 Aug; 73(2):457-9. PubMed ID: 16103622
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
[TBL] [Abstract][Full Text] [Related]
18. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK
Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291
[TBL] [Abstract][Full Text] [Related]
20. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
